Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 85
Oncology Drugs 84
Optical 76
Optical Disorders Drugs 75
Immune Disorders Drugs 72
Cardiovascular Drugs 51
Musculoskeletal Disorders Drugs 39
Dermatological Drugs 38
Biopharmaceuticals 36
Biotechnology 31
Genomics 29
Clinical Trials 29
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 23
Skin Cancer Drugs 21
Central Nervous System Drugs 19
Infectious Diseases Drugs 17
Respiratory Drugs 17
Allergy and Immunology 16
Infusions and Injectables 14
Gastrointestinal Drugs 14
Allergy Drugs 14
Drugs by Therapeutic Area 13
Lung Cancer Drugs 11
Dermatology 10
Hematological Drugs 10
Oncology 10
Leukemia Drugs 9
Needles and Syringes 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Biosimilars and Biosuperiors 7
Enzymes 6
Vaccines 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Ovarian Cancer Drugs 5
Transdermal and Transmucosal Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Cardiovascular Devices 4
Drug Delivery 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Proteomics 3
Laboratory Equipment 3
Pediatrics 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Pharmacoeconomics 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Cardiology 2
Endocrinology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

701 Results (Page 27 of 36)
- Relevance
  Sort by

Anti-VEGF Treatments Drugs for Wet AMD Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

 Report
January 2025
85 Pages
Global

From

€3500EUR$4,271USD£3,108GBP

Diphtheria Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Aspergillosis Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Encephalitis Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
October 2024
249 Pages
Global

From

€6979EUR$7,950USD£5,988GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Lipodystrophy - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1317EUR$1,500USD£1,130GBP

Throat Cancer Therapeutics Market 2024-2028

 Report
December 2023
158 Pages
Global

From

€2195EUR$2,500USD£1,883GBP

Antiviral Combination Therapy Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Systemic Aspergillosis and Systemic Candidiasis Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Posterior Segment Eye Disorders - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
120 Pages
Global

From

€4170EUR$4,750USD£3,578GBP

Controlled Substance Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Ethical Pharmaceuticals Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Rheumatology Arthritis Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
December 2022
118 Pages
Global

From

€3950EUR$4,500USD£3,390GBP

Familial Hypercholesterolemia - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€6979EUR$7,950USD£5,988GBP

Ophthalmic Disease Therapeutics Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3643EUR$4,150USD£3,126GBP

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) - Global Forecast to 2026

 Report
November 2021
201 Pages
Global

From

€4345EUR$4,950USD£3,729GBP

Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
120 Pages
Global

From

€1756EUR$2,000USD£1,507GBP

Protein Inhibitors Market Report 2025

 Report
April 2025
175 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Ophthalmic Devices Market Report 2025

 Report
April 2025
400 Pages
Global

From

€3941EUR$4,490USD£3,382GBP

Eczema Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

 Report
December 2023
180 Pages
Global

From

€2195EUR$2,500USD£1,883GBP

701 Results (Page 27 of 36)
- 1
- 25
- 26
- 27
- 28
- 29

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.